---
schema_version: "secwatch.filing_event.v1"
accession: "0001867096-25-000104"
form_type: "8-K"
ticker: "XERS"
cik: "0001867096"
company_name: "Xeris Biopharma Holdings, Inc."
filed_at: "2025-06-04T23:59:59+00:00"
generated_at: "2026-05-20T00:17:02.826842+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# Xeris Biopharma reports Annual Meeting voting results; all proposals approved

## Summary
- Three Class I directors elected: Bormann (57.1M for), Brady (76.5M for), Kong (75.9M for).
- Ratification of Ernst & Young as auditor for FY2025: 110.1M for, 0.7M against.
- Advisory say-on-pay compensation vote passed: 72.2M for, 5.6M against, 0.9M abstain.
- All proposals passed with required votes; no material changes to board or auditor.

## SEC filing metadata
- accession: 0001867096-25-000104
- form_type: 8-K
- ticker: XERS
- cik: 0001867096
- company_name: Xeris Biopharma Holdings, Inc.
- filed_at: 2025-06-04T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1867096/000186709625000104/0001867096-25-000104-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1867096/000186709625000104/xers-20250604.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001867096-25-000104
- JSON: https://secwatch.observer/filing/0001867096-25-000104.json
- Plain text: https://secwatch.observer/filing/0001867096-25-000104.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.